UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000049699
Receipt number R000056495
Scientific Title Effect of Backward treadmill gait training on the improvement of walking ability in chronic stroke
Date of disclosure of the study information 2022/12/05
Last modified on 2022/12/28 22:05:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of Backward treadmill gait training on the improvement of walking ability in chronic stroke

Acronym

Effect of Backward treadmill gait training on the improvement of walking ability in chronic stroke

Scientific Title

Effect of Backward treadmill gait training on the improvement of walking ability in chronic stroke

Scientific Title:Acronym

Effect of Backward treadmill gait training on the improvement of walking ability in chronic stroke

Region

Japan


Condition

Condition

stroke

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Effects of Backward Treadmill Gait Training on Chronic Stroke Patients

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II,III


Assessment

Primary outcomes

Berg Balance Scale
Before and After Intervention

Key secondary outcomes

Walking parameters: 10m walking test
reaction force meter
3D motion analysis: hip joint angle, knee joint angle, ankle joint angle during walking
Balance function: Mini-BESTest, ABC Scale
2D motion analysis: G.A.I.T
FMA lower extremity


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Backward Treadmill Walking
10 days
30 minutes per day
body Weight Support treadmill walking(BWSST)

Interventions/Control_2

Forward Treadmill Walking
10 days
30 minutes per day
body Weight Support treadmill walking(BWSST)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

Stroke patients who have had a stroke for more than 6 months after onset
Hemiplegia due to unilateral hemispheric lesion
Patients who can walk 10m or more independently with the use of assistive devices or orthotics
No serious aphasia or cognitive impairment
No contraindications to exercise therapy

Key exclusion criteria

Serious cardiac disease: unstable angina, myocardial infarction of short duration from onset, noncompensated congestive heart failure, acute pulmonary heart, poorly controlled arrhythmia, severe aortic valve stenosis, active myocarditis, endocarditis, etc.
Uncontrolled hypertension
Acute systemic illness or fever
Recent pulmonary embolism, acute pulmonary heart, severe pulmonary hypertension
Complications of severe hepatic or renal dysfunction
Complication of serious orthopedic disease that interferes with lower limb movement
Complication of severe cognitive impairment or severe psychiatric disease
Other metabolic abnormalities (e.g. acute thyroiditis)
Patients with spontaneous pain or inflammation of the hip, knee, or ankle joints
Patients with a history of hip, knee, or ankle joint fracture or traumatic tendon injury
Patients with contractures of the hip, knee, or ankle joints
Patients with impaired consciousness
Patients for whom written consent could not be obtained.
Other patients who are deemed by the treating physician to be unsuitable for enrollment in this clinical trial.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Taiyo
Middle name
Last name Kawaguchi

Organization

Keio University

Division name

Department of Rehabilitation

Zip code

160-8582

Address

35 Shinanomachi, Shinzyuku, Tokyo

TEL

03-3353-1211

Email

t.kawaguchi123@keio.jp


Public contact

Name of contact person

1st name Taiyo
Middle name
Last name Kawaguchi

Organization

Keio University

Division name

Department of Rehabilitation

Zip code

160-8582

Address

35 Shinanomachi, Shinzyuku, Tokyo

TEL

03-3353-1211

Homepage URL


Email

t.kawaguchi123@keio.jp


Sponsor or person

Institute

Keio University
Department of Rehabilitation

Institute

Department

Personal name



Funding Source

Organization

Keio University
Department of Rehabilitation

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

none

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Keio University

Address

35 Shinanomachi, Shinzyuku, Tokyo

Tel

03-3353-1211

Email

t.kawaguchi123@keio.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

慶應義塾大学病院(東京都)


Other administrative information

Date of disclosure of the study information

2022 Year 12 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2022 Year 12 Month 05 Day

Date of IRB

2022 Year 11 Month 24 Day

Anticipated trial start date

2023 Year 01 Month 04 Day

Last follow-up date

2024 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 12 Month 05 Day

Last modified on

2022 Year 12 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056495


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name